596 related articles for article (PubMed ID: 25265132)
21. Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.
Hermanns K; Junker U; Nolte T
Expert Opin Pharmacother; 2012 Feb; 13(3):299-311. PubMed ID: 22224497
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study.
Cuomo A; Russo G; Esposito G; Forte CA; Connola M; Marcassa C
Am J Hosp Palliat Care; 2014 Dec; 31(8):867-76. PubMed ID: 24249829
[TBL] [Abstract][Full Text] [Related]
23. Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.
Gatti A; Casali M; Lazzari M; Tufaro G; Gafforio P; Silvestri C; Marcassa C; Sabato AF
Adv Ther; 2013 Jan; 30(1):41-59. PubMed ID: 23269562
[TBL] [Abstract][Full Text] [Related]
24. Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer.
Clemens KE; Quednau I; Klaschik E
Int J Clin Pract; 2011 Apr; 65(4):472-8. PubMed ID: 21401835
[TBL] [Abstract][Full Text] [Related]
25. Prolonged-release oxycodone/naloxone in opioid-naïve patients - subgroup analysis of a prospective observational study.
Hesselbarth S; Hermanns K; Oepen P
Expert Opin Pharmacother; 2015 Mar; 16(4):457-64. PubMed ID: 25612469
[TBL] [Abstract][Full Text] [Related]
26. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
[TBL] [Abstract][Full Text] [Related]
27. Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].
van Dongen VC; Vanelderen PJ; Koopmans-Klein G; van Megen YJ; Van Zundert J; Huygen FJ
Int J Clin Pract; 2014 Nov; 68(11):1364-75. PubMed ID: 24853258
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.
Sandner-Kiesling A; Leyendecker P; Hopp M; Tarau L; Lejcko J; Meissner W; Sevcik P; Hakl M; Hrib R; Uhl R; Dürr H; Reimer K
Int J Clin Pract; 2010 May; 64(6):763-74. PubMed ID: 20370845
[TBL] [Abstract][Full Text] [Related]
29. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone.
Morlion B; Clemens KE; Dunlop W
Clin Drug Investig; 2015 Jan; 35(1):1-11. PubMed ID: 25479959
[TBL] [Abstract][Full Text] [Related]
30. Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.
Trenkwalder C; Chaudhuri KR; Martinez-Martin P; Rascol O; Ehret R; Vališ M; Sátori M; Krygowska-Wajs A; Marti MJ; Reimer K; Oksche A; Lomax M; DeCesare J; Hopp M;
Lancet Neurol; 2015 Dec; 14(12):1161-70. PubMed ID: 26494524
[TBL] [Abstract][Full Text] [Related]
31. Effect of prolonged-released oxycodone/naloxone in postoperative pain management after total knee replacement: a nonrandomized prospective trial.
Oppermann J; Bredow J; Spies CK; Lemken J; Unglaub F; Boese CK; Dargel J; Eysel P; Zöllner J
J Clin Anesth; 2016 Sep; 33():491-7. PubMed ID: 27555214
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients.
Guerriero F; Sgarlata C; Marcassa C; Ricevuti G; Rollone M
Clin Interv Aging; 2015; 10():1-11. PubMed ID: 25565782
[TBL] [Abstract][Full Text] [Related]
33. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives.
Mehta V; Alaward S; Kuravinakop S; Nikolic S
Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899
[TBL] [Abstract][Full Text] [Related]
34. Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study.
Hesselbarth S; Löwenstein O; Cegla T
Scand J Pain; 2014 Apr; 5(2):75-81. PubMed ID: 29913668
[TBL] [Abstract][Full Text] [Related]
35. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
[TBL] [Abstract][Full Text] [Related]
36. Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice.
Schutter U; Grunert S; Meyer C; Schmidt T; Nolte T
Curr Med Res Opin; 2010 Jun; 26(6):1377-87. PubMed ID: 20380506
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain.
Madeo G; Schirinzi T; Natoli S; Pierantozzi M; Stefani A; Dauri M; Pisani A
J Neurol; 2015 Sep; 262(9):2164-70. PubMed ID: 26134157
[TBL] [Abstract][Full Text] [Related]
38. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
Leppert W
Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials.
Löwenstein O; Leyendecker P; Lux EA; Blagden M; Simpson KH; Hopp M; Bosse B; Reimer K
BMC Clin Pharmacol; 2010 Sep; 10():12. PubMed ID: 20920236
[TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.
Guerriero F; Roberto A; Greco MT; Sgarlata C; Rollone M; Corli O
Drug Des Devel Ther; 2016; 10():1515-23. PubMed ID: 27143857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
